BiopatchTM - a new concept in antimicrobial dressings for invasive devices-: . A. r -. TI t..4 .

1998 
A randomised controlled trial (RCT) was conducted to assess the reduction in the rate of catheter-related infections associated with the BiopatchTM dressing (Johnson B Johnson Medical Inc., Arlington, Texas, USA) used for insertion-site management of central venous catheters (CVCs) placed in the intensive care unit. Patients having a CVC placed were randomly assigned to receive either a BiopatchTM keyhole dressing in addition to the occlusive Opsite N 3000TM (Smith and Nephew Medical Ltd, Hull, UK) (experimental group) or the Opsite N 3000TM alone (control group).
    • Correction
    • Cite
    • Save
    • Machine Reading By IdeaReader
    6
    References
    0
    Citations
    NaN
    KQI
    []